SRIJAN TIWARI

Drug & Cosmetics Legal Services in Delhi — Advocate Srijan Tiwari

Six specialised practice areas. One focus: protecting India's pharmaceutical and cosmetics corporations from the legal consequences of drug law enforcement — at the Delhi High Court and beyond.

What legal services does Advocate Srijan Tiwari provide?

Advocate Srijan Tiwari provides exclusive drug and cosmetics litigation services in Delhi — covering NSQ defence at trial courts, Delhi High Court representation, pharma regulatory dispute resolution, corporate pharmaceutical counsel, and cosmetics law compliance. All services are available only to pharmaceutical and cosmetics corporations, not individuals.

Drug & Cosmetics Litigation

Full-spectrum courtroom representation under the Drugs and Cosmetics Act, 1940.

When a pharmaceutical or cosmetics company receives a prosecution notice, court summons, or is named in a complaint under the Drugs and Cosmetics Act, the stakes are immediate and significant. Officers of the company can face criminal liability. The company faces reputational damage. The business risks disruption.

Advocate Srijan Tiwari has handled hundreds of such matters across Delhi district courts and the Delhi High Court over 14 years. His approach is systematic: first assess the quality of the prosecution's evidence, identify procedural lapses in the seizure or sampling process, challenge the testing methodology, and deploy targeted legal arguments at every stage of the proceedings.

Whether it is a defect in the Form 29 report, a chain of custody issue with the drug sample, or a flaw in the testing laboratory's accreditation — no stone is left unturned. Corporate clients retain us precisely because we know which stones to look under.

For Whom

Pharmaceutical manufacturers, API producers, drug distributors and stockists, cosmetics companies — all corporate entities.

What We Handle

  • Prosecution defence from complaint stage to final disposal
  • Bail applications and anticipatory bail for company officers
  • Cross-examination strategy for government drug inspectors
  • Challenge to drug testing lab reports and testing methodology
  • Trial court appearances across all Delhi districts
  • Revision and appeal at Sessions Court and Delhi High Court

NSQ Defence at Trial Courts

Specialised defence strategy for Not of Standard Quality prosecutions in Delhi.

Not of Standard Quality (NSQ) cases are the most common form of criminal prosecution under the Drugs and Cosmetics Act. State drug authorities collect drug and cosmetic samples from manufacturing facilities, warehouses, and distribution points. When a sample fails testing, a prosecution follows — often without notice to the company.

Defending NSQ cases requires more than legal knowledge. It requires understanding pharmaceutical analytical chemistry, GMP (Good Manufacturing Practices), pharmacopoeial standards, and the specific testing protocols that government labs follow. Advocate Srijan Tiwari's team has this technical depth, built through 14 years of handling NSQ defences across all categories of drugs and cosmetics.

Our NSQ defence strategy typically challenges the sample collection procedure (form compliance, container integrity, sealing), the drug testing process (Lab accreditation, pharmacopoeial method compliance, analyst qualification), and the legal framework (whether the alleged defect amounts to NSQ or a minor technical deviation). This comprehensive approach has delivered results for corporations across Delhi and beyond.

For Whom

Pharmaceutical manufacturers, generic drug companies, herbal/ayurvedic companies, cosmetics manufacturers facing NSQ prosecution.

What We Handle

  • Analysis of sample collection forms and procedure for defects
  • Challenge to government analyst's report and testing methodology
  • Pharmacopoeial standard interpretation for defence
  • Representation at Magistrate Court during trial
  • Application for retesting and reference lab referral
  • Coordination with company's quality assurance team for technical inputs

Delhi High Court Representation

Senior advocacy at the Delhi High Court for all drug law matters.

The Delhi High Court is the supreme judicial forum for challenging central drug regulatory actions and appellate drug law matters in Delhi. Writ petitions under Article 226 of the Constitution are the primary vehicle for challenging CDSCO orders, drug bans, import restrictions, and arbitrary enforcement actions.

Advocate Srijan Tiwari practices exclusively at the Delhi High Court, appearing personally in matters that require the highest level of advocacy. His institutional familiarity with the Court's procedures, its approach to drug law matters, and the judicial positions that have developed over his 14 years of practice gives corporate clients a significant advantage.

Whether the matter is a writ challenging a drug recall order, an appeal against a trial court conviction, a petition against a drug licence suspension, or a contempt matter — our High Court practice delivers the quality and consistency that corporate legal departments demand.

For Whom

Pharmaceutical and cosmetics corporations facing central drug regulatory action requiring High Court intervention.

What We Handle

  • Writ petitions under Article 226 challenging CDSCO and state drug authority orders
  • Appeals against trial court convictions under the Drugs and Cosmetics Act
  • Revision petitions challenging interlocutory orders
  • Contempt proceedings against regulatory authorities
  • Stay applications against coercive regulatory action
  • PIL-related defence for pharmaceutical industry interests

Pharma Regulatory Disputes

Legal challenges to drug authority orders, licence actions, and regulatory overreach.

Indian pharmaceutical companies operate under a complex web of regulatory authorities — the Drug Controller General of India (DCGI) at the central level, and state drug controllers in every state. When these authorities issue orders that are arbitrary, procedurally flawed, or exceed their legal powers, the consequences for a company can be catastrophic.

Licence suspensions halt manufacturing. Import restriction orders block critical raw materials. Show cause notices demand responses within days. Quality alerts damage commercial relationships with buyers. Our regulatory dispute practice is designed to respond to all of these with speed, precision, and legal force.

We assess every regulatory order against the legal framework and find the argument that is most likely to succeed — whether it is a jurisdictional challenge, a procedural natural justice violation, or a substantive legal error in the order. Our track record in regulatory disputes at both the administrative level and the courts speaks for itself.

For Whom

Pharmaceutical companies facing licence suspension, drug approval disputes, or regulatory enforcement actions.

What We Handle

  • Response drafting to drug authority show cause notices
  • Representation in personal hearings before drug regulatory authorities
  • Challenge to drug licence suspension and cancellation orders
  • Appeal against CDSCO product approval rejections
  • Regulatory strategy advisory to prevent prosecution
  • Liaison and correspondence with CDSCO and state drug authorities

Corporate Pharmaceutical Counsel

Standing legal advisory for pharma corporations — prevention is better than prosecution.

The most sophisticated pharmaceutical corporations know that the best drug law litigation is the litigation that never has to happen. That means having a drug law expert on retainer who can advise before a new product launch on its regulatory risk, review quality systems before a drug authority inspection, and guide the response when a show cause notice arrives — before it becomes a prosecution.

Advocate Srijan Tiwari offers a standing corporate counsel arrangement for pharmaceutical and cosmetics companies of sufficient scale and complexity. This means regular advisory calls, document review, regulatory correspondence guidance, and immediate availability when a drug law crisis emerges.

Clients on this retainer benefit not just from legal advice, but from the institutional knowledge of 14 years of drug law practice — patterns of regulatory enforcement, successful strategies in similar cases, and early warning systems for regulatory risks that a company's internal team may not see.

For Whom

Mid-to-large pharmaceutical manufacturers, multinational pharma companies with Indian operations, and rapidly scaling drug companies.

What We Handle

  • Pre-launch regulatory risk assessment for new products
  • Drug authority inspection preparation and advisory
  • Quality system documentation review for legal compliance
  • Immediate response advisory when regulatory notices arrive
  • Monthly regulatory law updates specific to client's product portfolio
  • Training sessions for company's legal and regulatory teams

Cosmetics Law Compliance & Litigation

Specialised representation for cosmetics companies under Indian and international regulatory frameworks.

Cosmetics law in India underwent a fundamental transformation with the Cosmetics Rules, 2020. BIS certification requirements for certain categories, strengthened enforcement against misbranded and spurious cosmetics, and increased scrutiny of imported cosmetics have all created new compliance challenges — and new prosecution risks.

Advocate Srijan Tiwari handles cosmetics law as an integral part of his practice — not as an afterthought. Cosmetics prosecutions under the Drugs and Cosmetics Act (which governs cosmetics as well) follow the same NSQ and misbranding framework as drug prosecutions, but with cosmetics-specific technical standards that require specialised understanding.

We have represented cosmetics companies facing NSQ prosecution for cosmetic preparations, misbranding cases, and import-related regulatory disputes. Our understanding of BIS standards, international cosmetics regulatory frameworks, and the technical definitions of cosmetics quality standards gives cosmetics corporate clients a genuine legal advantage.

For Whom

Cosmetics manufacturers (domestic and imported brands), FMCG companies with cosmetics divisions, beauty product importers and distributors.

What We Handle

  • NSQ defence for cosmetic products (creams, shampoos, colours, etc.)
  • Misbranding and spurious cosmetics defence
  • BIS certification compliance advisory
  • Import-related cosmetics regulation disputes
  • Cosmetics licence advisory and dispute resolution
  • High Court challenges to cosmetics regulatory orders

How We Work — From First Contact to Case Resolution

A structured, transparent process designed for the way corporate legal departments operate.

01

Initial Enquiry

Contact us via WhatsApp or phone. Provide a brief description of your legal matter — prosecution notice received, regulatory order issued, or advisory requirement.

02

Confidential Consultation

We schedule a detailed consultation within 24 hours. You share all relevant documents. We assess the case, identify the legal issues, and provide an initial strategic view.

03

Legal Strategy Brief

We prepare a written legal strategy brief covering the legal position, proposed action plan, anticipated timeline, and fee structure for your review.

04

Mandate & Execution

On acceptance, we execute the legal strategy with full force — court appearances, regulatory correspondence, document preparation, and interim orders where required.

05

Ongoing Communication

Throughout the matter, you receive regular updates on proceedings, court dates, and strategic decisions. Corporate clients are never left wondering about their case status.

Drug Law Services Across Delhi & Beyond

Our primary court practice is in Delhi — at the Delhi High Court and district courts across all Delhi zones (North, South, East, West, Central). We serve pharmaceutical and cosmetics companies operating from:

Okhla Industrial Area
Wazirpur (North Delhi)
Narela Industrial Zone
Bawana Industrial Belt
Badli (North West Delhi)
Patparganj (East Delhi)
Jasola (South Delhi)
Connaught Place
Noida (NCR)
Gurgaon / Gurugram

For matters in other states requiring coordination, we provide drug law strategy and work with local advocates to ensure the same standard of pharmaceutical legal expertise.

Need Drug Law Services in Delhi?

Whether your company has just received an NSQ prosecution notice, a drug authority show cause, or you need a standing legal advisory arrangement — the first step is a conversation.

Questions About Our Drug Law Services in Delhi

What types of companies does Advocate Srijan Tiwari represent?
Advocate Srijan Tiwari represents only pharmaceutical and cosmetics corporations — not individual retailers or small distributors. His clients include domestic pharma manufacturers, multinational companies with India operations, API producers, generic drug companies, herbal product makers, and cosmetics companies of all sizes.
How quickly can Advocate Tiwari take on an urgent matter?
For urgent matters such as arrests, raids, licence suspension orders, or court summons with short deadlines, the office responds within the same working day. A consultation can be arranged within 24 hours of contact.
Does Advocate Tiwari handle matters outside Delhi?
The primary practice is at the Delhi High Court and district courts within Delhi. For matters in other High Courts or trial courts across India, we advise on strategy and coordinate with trusted advocates in those jurisdictions — ensuring the same quality of drug law expertise regardless of geography.
What is the typical outcome in NSQ cases handled by this firm?
While outcomes depend entirely on the specific facts and evidence, the firm has a strong track record in NSQ defences — obtaining acquittals at trial stage, successful stays from Delhi High Court, and administrative remedies at drug authority level. The approach in every case is to identify the strongest legal and technical arguments available.
What documents should a company prepare before the first consultation?
For prosecution matters: the prosecution complaint, form 29 (government analyst report), seizure memo, and any court notices received. For regulatory disputes: the show cause notice, authority order, licence documents, and prior correspondence. The more complete the picture, the more precise our initial assessment.
Does the firm take cases on a retainer basis?
Yes. Companies that frequently deal with drug regulatory matters or have ongoing litigation benefit from a standing retainer arrangement. This provides access to immediate advisory, priority response, and a deep institutional understanding of the company's regulatory profile — which improves outcomes in every matter.
How does the firm stay current with changes in drug law and regulations?
The firm's research team tracks all CDSCO circulars, gazette notifications, and judicial decisions on drug law on a daily basis. Advocate Tiwari personally reviews significant regulatory developments. Retainer clients receive periodic regulatory law updates specific to their product portfolio.

Need Drug & Cosmetics Legal Services in Delhi?

Contact Advocate Srijan Tiwari today. Same-day response. Corporate clients only. Delhi High Court specialist.